Telix Pharmaceuticals announces shareholder meeting
Bitget2026/09/21 01:56- Telix Pharmaceuticals will hold an extraordinary general meeting in November 2026.
- Shareholders will vote on the proposed merger to acquire ITM Isotope Technologies Munich for upfront consideration of USD 1.65 billion.
- The deal includes payment of about USD 1.25 billion in Telix shares, assumption of USD 302 million net debt, closing adjustments.
- Meeting agenda also covers potential contingent consideration of up to USD 700 million tied to FDA approvals and ITM-11 sales milestones.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Royal Caribbean Cruises (RCL.US) is reportedly close to acquiring a 50% stake in Sandals for nearly 3 billions USD, expanding into the all-inclusive land resort business.
Royal Caribbean is close to finalizing a 3 billion dollar deal to acquire a 50% stake in Sandals.
AOA-HI Dartagnan Fund cuts Poongwon Precision stake to 4.95% from 5.29%
Netflix (NFLX.US) downgraded twice in one week: HSBC cites YouTube competition, Wells Fargo concerns about engagement and content strategy
HSBC analyst Mohamed Kalouf downgraded the rating of streaming giant Netflix (NFLX.US) from "Buy" to "Hold," and lowered the target price by 21% to $76.
Canadian Dollar seems vulnerable as Iran diplomacy hopes weigh on oil prices
Crypto prices
More
